Evelien Heylen

The decrease in procarboxypeptidase U (TAFI) concentration in acute ischemic stroke correlates with stroke severity, evolution and outcome

Raf Brouns, Evelien Heylen, Johan Willemse et al. · Journal of Thrombosis and Haemostasis · 2009 · 39 citations · Full text

Thrombosis, Cerebral Vascular Regulation, Cardiovascular Disease +15

Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients

Raf Brouns, Evelien Heylen, Rishi Sheorajpanday et al. · Clinical Neurology and Neurosurgery · 2008 · 31 citations

Thrombosis, Ischemic Stroke Patients, Cerebral Vascular Regulation +15

Glucose‐6‐phosphate dehydrogenase deficiency: not exclusively in males

Leonie van den Broek, Evelien Heylen, Machiel van den Akker · Clinical Case Reports · 2016 · 31 citations · Full text

Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma

Evelien Heylen, Sebastiaan Van Goethem, Johan Willemse et al. · Analytical Biochemistry · 2009 · 21 citations

Thrombopoiesis, Thrombosis, Biochemistry +15

Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia

Evelien Heylen, Predrag Miljić, Johan Willemse et al. · Thrombosis Research · 2009 · 16 citations

Thrombopoiesis, Thrombosis, Venous Thrombosis +12